On the stock market since 2023, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades 26% below its peak. The market has trimmed its expectations for the company.
Sales run at $114.3M a year. A small number, but proof the product has real buyers.
It pays out $2.47 per share each year — regular cash for whoever holds the stock.
A loss of $24.0M against $114.3M in annual sales.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, ABXL sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: ABXL is a high-risk stock — not yet profitable, and its future rides on its product catching on.